Muhammad Pate, Former Minister of State for Health of Nigeria

Leadership Lessons Learned: Eradicating Polio in Nigeria Thursday, September 8, 2016 Dr. Muhammad Ali Pate served as Nigeria’s Minister of State for Health from 2011-2013. Prior, he was the Executive Director of the National Primary Health Care Development Agency (NPHCDA), in Abuja, Nigeria. Dr. Pate is currently a professor at the Duke University Global Health Institute. He also serves on the agenda committee of the World Economic Forum and is a member of the Strategic Advisory Group of Experts (SAGE) on … Continue reading “Muhammad Pate, Former Minister of State for Health of Nigeria”

John Lechleiter, Chairman, President and Chief Executive Officer, Eli Lilly and Company

Leadership Along the Path We Have Chosen Tuesday, March 31, 2015 John Lechleiter has served as president and chief executive officer of Eli Lilly and Company since, and became chairman of the board of directors in 2009. John joined Lilly in 1979 as a senior organic chemist in process research and     development and became head of that department.  He began serving as director of pharmaceutical product development for the Lilly Research Centre Limited in Windlesham, England, and later held roles … Continue reading “John Lechleiter, Chairman, President and Chief Executive Officer, Eli Lilly and Company”

Swati Piramal, Director of Piramal Healthcare

Paradigm of Leadership: A Women’s View Dr. Swati Piramal (MPH ’92) is the Director of Piramal Healthcare, a leading drug discovery company which aims to bring affordable medicines to reduce the burden of disease globally. Dr. Piramal leads a team of scientists in cancer, diabetes, inflammation and infectious disease research. As Director of the Piramal Foundation, which is engaged in inter-disciplinary and field based education, she helps promote health in rural India with HMRI—a mobile health service; women’s empowerment projects; … Continue reading “Swati Piramal, Director of Piramal Healthcare”

Julie Gerberding, President, Merck Vaccines

Crises, Crossroads, and Credibility Julie Gerberding is president of Merck Vaccines. She is responsible for the commercialization of the current portfolio of vaccines, planning for the introduction of vaccines from the company’s vaccine pipeline, and accelerating Merck’s ongoing efforts to broaden access to its vaccines in the developing world. Before joining Merck, Dr. Gerberding led the Centers for Disease Control and Prevention (CDC) as director from 2002 to 2009. In this position, she was responsible for coordinating more than 40 … Continue reading “Julie Gerberding, President, Merck Vaccines”